Yao Chen is a highly motivated principal scientist specializing in oncology translational science and clinical biomarkers. With extensive experience in both translational research and clinical programs at Adaptimmune and GSK, Yao has led efforts in analyzing biomarker data to enhance the efficacy and safety of cell therapy products. Currently serving as a principal scientist in oncology clinical research at Merck, Yao continues to leverage a strong background in immunology, including a Ph.D. from the University of Alabama at Birmingham, and previously conducted pioneering research as a postdoctoral fellow at Duke University. Their collaborative skills have facilitated successful alliances with academic institutions and contributed to the advancement of cancer therapies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices